rediff.com
News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Rediff.com  » Sports » Tour de France: Major doping scandals
This article was first published 13 years ago

Tour de France: Major doping scandals

Last updated on: July 1, 2011 09:18 IST

Image: Festina rider Laurent Brochard

Factbox on the major doping scandals to hit cycling's Tour de France since 1998:

* 1998: Festina are kicked out of the Tour when medical team member Willy Voet is arrested at the French border after customs officers seize banned substances, including the blood-boosting drug erythropoietin (EPO).

-- The team's riders later admit taking performance-enhancing drugs. Top rider Richard Virenque is banned for nine months, while team director Bruno Roussel and Voet are fined and given suspended jail sentences.

Photographs: Getty Images

Landis was the first Tour winner to fail a drugs test

Image: Floyd Landis

2006: American Floyd Landis becomes the first Tour winner to fail a drugs test during the race after testing positive for excessive levels of the male sex hormone testosterone. Landis, who denies using performance-enhancing drugs, is stripped of the title and given a two-year ban which ended on January 30, 2009. He finally admits to doping in May 2010 and accuses former team mates, including compatriot Lance Armstrong of also cheating, charges that Armstrong denies.

-- Germany's 1997 Tour winner Jan Ullrich and Giro d'Italia champion Ivan Basso are among nine competitors withdrawn on the eve of the prologue after being implicated in a Spanish doping investigation, Operation Puerto.

-- Spain launched Operation Puerto in 2006 after raids at addresses in Madrid and Zaragoza uncovered anabolic steroids, blood transfusion equipment and more than 200 code-named blood bags, some of which were linked to leading cyclists.

-- Ullrich, who denies taking banned substances, is subsequently sacked by his T-Mobile team and retires from competition in February 2007.

-- Basso admits his involvement in the scandal to the Italian Olympic Committee in May 2007 and is banned for two years. Basso returns to competition in 2009 and recovers his flair, winning his second Giro d'Italia in May 2010.

Vinokourov tested positive for blood doping in 2007

Image: Alexandre Vinokourov

2007: Pre-race favourite Alexandre Vinokourov tests positive for blood doping after winning a time trial on July 21. A one-year ban is later increased to two years by the Court of Arbitration for Sport (CAS).

Ricco was kicked out of the 1998 Tour

Image: Riccardo Ricco

2008: Italian Riccardo Ricco is kicked out of the race after failing a test for the new generation of EPO called CERA (Continuous Erythropoiesis Receptor Activator). Saunier Duval announce they are withdrawing their sponsorship of the team.

-- Austrian Bernhard Kohl, third overall and the race's top climber, as well as Italian Leonardo Piepoli and German Stefan Schumacher, are also found guilty of using CERA following retroactive tests.

Contador tested positive for clenbuterol

Image: Alberto Contador

2010: Alberto Contador, winner of the 2010 tour, tests positive for the banned anabolic agent clenbuterol during the race. He is cleared by the Spanish cycling federation (RFEC), but the International Cycling Union (UCI) and the World Anti-Doping Agency (WADA) appeal. Contador's CAS June hearing is postponed, allowing him to enter this year's race.

-- If found guilty, Contador, who has denied any wrongdoing, would face a possible two-year ban and be stripped of his 2010 Tour title.

Armstrong never failed a drugs test

Image: Lance Armstrong

2011: Seven-time Tour de France winner Armstrong is again accused of taking banned substances.

His former team mate Tyler Hamilton told the US television programme 60 Minutes he witnessed Armstrong inject himself with a blood-booster during the 1999 Tour de France won by Armstrong.

Armstrong has always denied taking banned substances and has repeatedly had to fend off accusations despite having never failed a drugs test.

Source: REUTERS
© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.